Historical record - last NADAC effective date: 2/23/2022
This NDC is on FDA's drug shortage list (posted Jan 19, 2023)
Reported reason: Discontinuation of the manufacture of the drug
Product Information
QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3118 per EA under NDC 65862016190. Its NADAC has been published 482 times since Nov 28, 2013.
FDA first approved this application on Aug 24, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB
QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDEStrength
12.5; 10 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862016190
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/23/2022
Active Ingredients
HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078450FDA Approved
8/24/2007
TE Code
AB
On Market Since
8/24/2007
Pharmacological Classes
Price Statistics
The NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has been published 482 times since Nov 28, 2013, and over the history we have for it it has declined 40.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3118 per EA |
|---|---|
| All-time high | $0.7092 (Feb 10, 2016) |
| All-time low | $0.3118 (Feb 23, 2022) |
| Median price | $0.5233 |
| Average price | $0.4993 |
| Largest weekly change | -40.4% (Feb 23, 2022) |
| Weeks tracked | 482 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-16.5%
All
-40.4%
Last surveyed Feb 15, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.3118 per EA (NDC 65862016190), effective Feb 15, 2023.
How has the price of QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has declined 40.4%. It has been tracked across 482 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
Since Nov 28, 2013, the NADAC for QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has ranged from a low of $0.3118 (Feb 23, 2022) to a high of $0.7092 (Feb 10, 2016), with a median of $0.5233 per EA.
Are there cheaper alternatives to QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB (NDC 65862016190) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Is QUINAPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB in shortage?
Yes — NDC 65862016190 is currently listed in FDA's drug shortage database (posted Jan 19, 2023). Reported reason: Discontinuation of the manufacture of the drug.